WebMar 3, 2024 · Price Why F-Star Therapeutics Inc’s (FSTX) Stock Is Up 16.55% As of Wednesday, February 01, F-Star Therapeutics Inc’s FSTX share price has surged by 16.55%, which has investors questioning if this is right time to sell. Jack Gilleland. Stock Grade Focus Is F-Star Therapeutics Inc (FSTX) Stock a Good Investment? WebMar 8, 2024 · F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing immunotherapies to transform the lives of patients with cancer. The Company's FS118 is the lead product candidate, which is in Phase II trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing FS222, FS120 ...
FSTX Institutional Ownership and Shareholders - F …
WebMar 9, 2024 · F-star has four second-generation immuno-oncology therapeutics in the clinic, each directed against some of the most promising immuno-oncology targets in … map files terraria
F-star Therapeutics, Inc. (FSTX) Stock Price, Quote & News …
WebMar 9, 2024 · According to the issued ratings of 5 analysts in the last year, the consensus rating for F-star Therapeutics stock is Hold based on the current 5 hold ratings for FSTX. The average twelve-month price prediction for F-star Therapeutics is $35.00 with a high price target of $35.00 and a low price target of $35.00. WebJul 15, 2024 · F-star Therapeutics, Inc. (NASDAQ:FSTX) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.52) earnings per … WebJul 8, 2024 · On July 7, 2024, invoX Pharma Limited (“invoX”) , a wholly owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) commenced a cash tender offer for all of the issued and outstanding shares of common stock of F-star Therapeutics, Inc. (“F-star”) (NASDAQ:FSTX) for a price of $7.12 per share. map field paintball vandalia illinois